Hennepin Life Sciences has a total of 14 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, Australia and Brazil. Its main competitors in its focus markets pharmaceuticals and environmental technology are 442 VENTURES LLC, GENG FUNENG and LAUB BIOCHEMICALS CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | Australia | 1 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Hong Kong | 1 | |
#8 | Israel | 1 | |
#9 | India | 1 | |
#10 | Republic of Korea | 1 | |
#11 | Mexico | 1 | |
#12 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Climate change adaptation technologies | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Schlievert Patrick | 9 |
#2 | Schlievert Patrick M | 3 |
#3 | Patrick Schlievert | 1 |
Publication | Filing date | Title |
---|---|---|
EP2838524A1 | Compositions for topical treatment of microbial infections |